Letter to Editor on Fawad et al. Comment on "Cost-Effectiveness Analysis of Ibuprofen versus Indomethacin or Paracetamol for the Treatment of Patent Ductus Arteriosus in Preterm Neonates" by Al-Shaibi et al

Curr Probl Cardiol. 2024 Jan;49(1 Pt C):102157. doi: 10.1016/j.cpcardiol.2023.102157. Epub 2023 Oct 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acetaminophen / therapeutic use
  • Cost-Effectiveness Analysis
  • Ductus Arteriosus, Patent* / drug therapy
  • Humans
  • Ibuprofen / therapeutic use
  • Indomethacin* / therapeutic use
  • Infant, Newborn

Substances

  • Indomethacin
  • Ibuprofen
  • Acetaminophen